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Iron, copper, zinc, and eight other minerals are classified as essential trace elements
because they present in minute in vivo quantities and are essential for life. Because
either excess or insufficient levels of trace elements can be detrimental to life (causing
human diseases such as iron-deficiency anemia, hemochromatosis, Menkes syndrome
and Wilson’s disease), the endogenous levels of trace minerals must be tightly regulated.
Many studies have demonstrated the existence of systems that maintain trace element
homeostasis, and these systems are highly conserved in multiple species ranging
from yeast to mice. As a model for studying trace mineral metabolism, the zebrafish
is indispensable to researchers. Several large-scale mutagenesis screens have been
performed in zebrafish, and these screens led to the identification of a series of metal
transporters and the generation of several mutagenesis lines, providing an in-depth
functional analysis at the system level. Moreover, because of their developmental
advantages, zebrafish have also been used in mineral metabolism-related chemical
screens and toxicology studies. Here, we systematically review the major findings of trace
element homeostasis studies using the zebrafish model, with a focus on iron, zinc, copper,
selenium, manganese, and iodine. We also provide a homology analysis of trace mineral
transporters in fish, mice and humans. Finally, we discuss the evidence that zebrafish is
an ideal experimental tool for uncovering novel mechanisms of trace mineral metabolism
and for improving approaches to treat mineral imbalance-related diseases.
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INTRODUCTION
As children of the Earth, humans are intimately connected to
our surroundings in many ways, and the relationship between
humans and minerals is perhaps the most enigmatic. Based
on their necessity for life and their limited quantities with
the human body, 11 elements are classified as trace minerals,
including iron (Fe), zinc (Zn), copper (Cu), selenium(Se), man-
ganese(Mn), iodine(I), molybdenum(Mo), fluorine (F), cobalt
(Co), chromium (Cr), and vanadium (V) (Fraga, 2005).
Metal trace minerals are biologically active primarily as metal-
loproteins formed by conjugating or binding with various protein
partners. Metalloproteins account for approximately half of all
proteins and perform a wide range of biological functions as
enzymes, transporters and signal transducers. In metallopro-
teins, metal trace minerals are essential components, acting at the
enzyme’s active site or by stabilizing the protein’s structure. Trace
mineral deficiencies can cause a number of diseases that can be
mild, severe, or even fatal. Conversely, excess levels of trace min-
erals can be toxic. For example, excess iron or copper produces
reactive oxygen species (ROS) via the Fenton reaction, resulting
in lipid peroxidation, DNA damage, altered calcium homeostasis,
and cell death (Stohs and Bagchi, 1995). Excess levels of redox-
inactive metals such as zinc are also harmful; the accumulation
of zinc triggers neuronal death in the brain and induces copper
deficiency. Thus, the balance of endogenous trace minerals must
be tightly regulated.
Organisms have evolved comprehensive systems for main-
taining trace element homeostasis; these systems are composed
primarily of transport proteins, storage proteins, and some hor-
mones. Our current knowledge regarding these regulatory factors
has come primarily from studies using model organisms rang-
ing from yeast to mice. Among these species, the zebrafish (Danio
rerio) has been a valuable vertebrate system with several unique
advantages. First, their small size, high fertility rate, and rapid
developmentmake zebrafish an ideal model for large-scale genetic
screens. Secondly, because they are fertilized ex vivo and are
optically transparent, zebrafish embryos are ideally suited for
experimental techniques such as gene knockout/knockdown and
overexpression. Because the embryos develop ex utero, zebrafish
are also an excellent model for studying pharmacology and tox-
icology in early developmental stages. Finally, the zebrafish is a
vertebrate species, and many of its genes and metabolic systems
are highly conserved with humans; indeed, 80% of genes and
expressed sequence tags (ESTs) are present in conserved synteny
groups between fish and humans (Barbazuk et al., 2000).
Here, we systematically review the major findings obtained
from zebrafish studies of trace element homeostasis, with a focus
on iron, zinc, copper, selenium, manganese, and iodine. We also
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performed a homology analysis of trace mineral transporters in
fish, mice and humans, and we summarize the available zebrafish
mutant models in the field. This review demonstrates that
zebrafish are an ideal experimental tool for investigating novel
mechanisms of trace mineral metabolism and for improving
therapeutic approaches for treating mineral imbalance-related
diseases.
ZEBRAFISH AND IRON METABOLISM
OVERVIEW OF IRON METABOLISM
Iron is present in nearly all living organisms. As an essential com-
ponent of heme and iron-sulfur cluster–containing proteins, iron
plays a central role in many biological activities, including oxygen
transport, cellular respiration, and DNA synthesis (Muckenthaler
and Lill, 2012). Of all the trace elements, the iron homeostasis
system is one of the best characterized, primarily because of iron’s
role in erythropoiesis and its causative relationships with iron-
deficiency anemia and hematochromatosis. To date, many major
proteins involved in the uptake, transport, storage and release of
iron have been identified (Figure 1).
Under normal conditions, dietary iron is absorbed by ente-
rocytes through Divalent Metal Transporter 1 (DMT1); from
there, it is exported to the circulation through Ferroportin
1 (Fpn1). In the blood, iron is transported in the form of
Transferrin (Tf)-Fe3+, which is taken up by endocytosis into
cells with surface Transferrin receptors (TfRs). Iron in the endo-
somes is then released to the cytoplasm and delivered to the
mitochondria, where it is used to make iron-sulfur (Fe-S) clus-
ters, to synthesize heme, or to be stored as Ferritin. Most
of the iron used for producing hemoglobin in erythrocytes is
obtained from the recycling iron pool released from senescent
red blood cells that are phagocytized by macrophages. Aside
from transport and storage proteins, Hepcidin—a peptide hor-
mone released by the liver—plays an important role in regulating
iron levels by binding to Fpn1 and promoting its internal-
ization. Other factors such as oxidoreductases [e.g., Duodenal
Cytochrome b (Dytb), Ceruloplasmin (Cp), Hephaestin (Heph),
and STEAP3) and modulatory proteins (e.g., Hemochromatosis
(HFE), Hemojuvelin (HJV), Iron Regulatory Protein (IRP) 1/2,
and Transmembrane Serine Protease 6 (TMPRSS6)] also play
an active role in iron metabolism (Muckenthaler and Lill, 2012;
Srai and Sharp, 2012). An overview of the protein homology and
expression patterns among fish and mammalian iron-regulating
proteins is provided in Table 1.
FIGURE 1 | Generalized overview of iron metabolism in vertebrate cells.
Dietary iron is absorbed by enterocytes through the concerted activity of the
reductase DCYTB and the transporter DMT1. Iron is then oxidized by HEPH
and exits the enterocytes through the iron exporter FPN1. Iron is transferred
as a complex with Transferrin (TF) in the bloodstream and is delivered to
target cells that express Transferrin receptors (TFRs) on their plasma
membrane. TF-Iron-TFR complexes are then endocytosed. In the endosome,
iron is released from TF by STEAP3 and then transported out of the
endosome through DMT1. The cytoplasmic iron then enters the labile iron
pool and is delivered by MFRN and siderophores to the mitochondria to be
used for the synthesis of heme and Fe-S clusters. Excess iron is stored in
Ferritin. Iron leaves the cell through FPN1, the plasma expression of which is
negatively regulated by Hepcidin. Proteins for which zebrafish knockout
and/or knockdown models are available are written in red.
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Table 1 | Iron metabolism–related proteins in zebrafish, mice, and humans.
Gene/Protein Function/Related diseases Tissue distribution Protein identity
(vs. H)
M% Z%
SLC11A2/DMT1 Intestinal iron absorption, intracellular iron
release/Hypochromic microcytic anemia
H Ubiquitous 89 71
M Yolk sac, intestine
Z Blood, gill, gut, lens, liver, YSL
SLC40A1/FPN 1 Cellular iron efflux/Hemochromatosis type 4 H Duodenum, macrophages, KCs, placenta,
kidney
91 68
M Placenta, intestine, bone marrow,
erythrocytes, liver, spleen
Z CNS, yolk syncytial layer, gill, gut, liver
HAMP/Hepcidin Cellular iron homeostasis/Hemochromatosis type 2B H Liver, heart 59 31a/32b
M Liver, lung, heart
Z Hamp1: gut, liver; hamp2: N.D.
HFE/HFE Regulator of Tf-TfR interaction/Hemochromatosis
type 1
H Ubiquitous 68 N.D.
M Ubiquitous
Z N.D.
HFE2/HJV Modulator of hepcidin expression/Hemochromatosis
type 2A
H Ubiquitous 87 44
M Skeletal muscle, liver, heart, prostate
Z Skeletal muscle, liver, notochord
TF /Transferrin Transport iron/atransferrinemia H Liver, spinal cord, lung, hypothalamus 72 41
M Liver, spinal cord, cerebellum, lung,
placenta, ovary, bladder
Z Liver, trunk musculature
TFRC/TFR1 Cellular iron uptake / N.D. H Fetal liver, pancreas, muscle, placenta,
early erythroid cells
77 44c/39d
M Placenta, intestine, muscle, osteoclasts,
microglia, bone marrow, liver, kidney
Z Tfr1a: blood, blood island; tfr1b: ubiquitous
TFR2/TFR2 Mediates cellular uptake of Tf-bound
iron/Hemochromatosis, type 3
H Liver, early erythroid cells 85 53
M Liver, bone, bone marrow
Z Liver
TMPRSS6/TMPRSS6 Iron homeostasis/Iron-refractory iron deficiency
anemia
H Ubiquitous 83 N.D.
M Liver
Z N.D.
SLC25A37 /Mitoferrin Mitochondrial iron transport/N.D. H Bone marrow, fetal liver, fetal lung, blood,
prostate, early erythroid cells
91 69
M Umbilical cord, spleen, bone, bone
marrow
Z Blood island, lateral plate mesoderm
CYBRD1/DCYTB Dietary iron absorption/N.D. H Ubiquitous 75 58
M Ubiquitous
Z N.D.
STEAP3/ STEAP3 Ferric-chelate reductase activity/Anemia,
hypochromic microcytic, with iron overload 2
H Ubiquitous 87 53
M Ubiquitous
Z N.D.
(Continued)
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Table 1 | Continued
Gene/Protein Function/Related diseases Tissue distribution Protein identity
(vs. H)
M% Z%
CP/Ceruloplasmin Oxidizes Fe(II) to Fe(III)/aceruloplasminemia H Ubiquitous 83 55
M Mammary gland, lung, liver, lens
Z Liver, gut, pancreas
HEPH/Hephaestin Transport of dietary iron from epithelial cells of the
intestinal lumen into the circulatory system/N.D.
H Ubiquitous 86 N.D.
M Intestine, stomach, ovary, brown adipose
Z N.D.
FTH1/Ferritin Store of iron in a soluble and nontoxic
state/hemochromatosis, type 5
H Ubiquitous 92 77e/76f
M Ubiquitous
Z fth1a: blood, eye; fth1b: N.D.
ACO1/IRP1 Interacts with mRNA to control the levels of iron
inside cells/N.D.
H Ubiquitous 93 82
M Ubiquitous
Z Blood
IREB2/IRP2 Iron-responsive element binding/N.D. H Ubiquitous 94 65
M Ubiquitous
Z Blood
FXN/Frataxin Regulates mitochondrial iron transport and
respiration/Friedreich’s ataxia
H Ubiquitous 73 43
M Ubiquitous
Z N.D.
GRX5/Glutaredoxin 5 Involved in the biogenesis of iron-sulfur
clusters/pyridoxine-refractory sideroblastic anemia
H Ubiquitous 94 59
M Ubiquitous
Z Blood island, dorsal aorta, heart, liver
ahamp1.
bhamp2.
ctfr1a.
d tfr1b.
efth1a.
f fth1b.
H, human; M, mouse; Z, zebrafish; N.D., Not determined; YSL, yolk syncytial layer; KC, Kupffer cells; CNS, central nervous system.
Zebrafish absorb waterborne iron via the gastrointestinal
tracts and the gills. The fish branchial iron uptake has high- and
low-affinity components, with Km of 5.9 nmol/l Fe and Vmax of
2.1 pmol/g·h at low Fe concentration (<40 nmol/1), and a linear
manner increase of the uptake rate at higher Fe concentration
(40–200 nmol/1) (Bury and Grosell, 2003). Zebrafish branchial
iron transport can be inhibited by high level of Cd, but not by
other divalent metals such as Zn, Cu, and Mn (Bury and Grosell,
2003). Moreover, low iron diet fed zebrafish exhibited a signifi-
cant increase in tissue Cd accumulation, suggesting an interaction
between Fe and Cd assimilation in fish (Cooper et al., 2006).
ZEBRAFISH MODELS OF IRON METABOLISM IDENTIFIED USING
FORWARD GENETIC SCREENS
The Nüsslein-Volhard lab performed two large-scale N-ethyl-N-
nitrosourea (ENU) mutagenesis screens in zebrafish and iden-
tified several thousand mutations that affect various aspects of
early development (Haffter et al., 1996). Using this strategy with
an anemic phenotype as the screening output, several mutant
zebrafish lines with defects in iron metabolism have been estab-
lished; these lines are summarized in Table 2.
Ferroportin 1
Although researches had long suspected that an iron exporter is
present in enterocytes, this was only confirmed in 2000 by studies
performed in the zebrafish mutant weissherbst (weh) (Donovan
et al., 2000). The wehmutant line was originally isolated from the
1996 Tübingen screen (Haffter et al., 1996) and was subsequently
found to have severe hypochromic anemia phenotypes, including
decreased hemoglobin levels, blocked erythroid maturation, and
reduced numbers of erythrocytes (Ransom et al., 1996; Donovan
et al., 2000). Interestingly, mutant embryos have significantly
lower iron levels in their erythroid cells compared with wild-type
fish, suggesting a circulatory iron deficiency. Indeed, the reduced
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Table 2 | Iron metabolism–related mouse and zebrafish knockout/knockdown models and their phenotypes.
Gene/Protein KO mouse models KO/KD zebrafish models References
SLC11A2/DMT1 Hypochromic microcytic anemiaa,b Hypochromic microcytic anemiac aRussell et al., 1970; bGunshin et al.,
2005a; cDonovan et al., 2002
SLC40A1/FPN1 Embryonic lethality; abnormal iron
homeostasisd,e
Hypochromic microcytic anemiaf dDonovan et al., 2005; eZohn et al., 2007;
fDonovan et al., 2000
HAMP/Hepcidin Massive iron accumulation in the liver,
pancreas, and heartg
N.D. gLesbordes-Brion et al., 2006
HFE/HFE Increased intestinal iron absorption, elevated
hepatic iron load, reduced duodenal iron
storesh,i
N.D. hVujic Spasic et al., 2007; iVujic Spasic et
al., 2008
HFE2/HJV Lack of hepcidin expression, severe iron
overloadj,k
N.D. jHuang et al., 2005a; kNiederkofler et al.,
2005
TF /TF Hypochromic microcytic anemia, iron-loading
in the liver, pancreas, heart, and brainl
Hypochromic anemiam lBartnikas et al., 2011; mFraenkel et al.,
2009
TFRC/TFR1 Anemia, hydrops fetalis, neurological
defectsn
Hypochromic anemiao nLevy et al., 1999; oWingert et al., 2004
TFR2/TFR2 Periportal hepatic iron loading, splenic iron
sparing, and elevated serum transferrin
saturations p
N.D. pRoetto et al., 2010
TMPRSS6/TMPRSS6 Microcytic anemia, female infertilityq,r N.D. qNai et al., 2010; rNai et al., 2012
SLC25A37 /MFRN No hemoglobinization in the yolk sac and
heart; die during organogenesiss
Hypochromic anemia, erythroid
maturation arrestt
sTroadec et al., 2011; tShaw et al., 2006
CYBRD1/DCYTB Alterations in liver weight and liver iron
contentu
N.D. uGunshin et al., 2005b
STEAP3/STEAP3 Anemiav N.D. vOhgami et al., 2005
CP/Ceruloplasmin Iron accumulation in the liver, spleen, brain;
iron deficiency anemia, impaired motor
coordinationw,x
N.D. wHarris et al., 1999; xCherukuri et al., 2005
HEPH/Hephaestin Hypochromic anemiay N.D. yVulpe et al., 1999
FTH1/Ferritin Embryonic lethality z N.D. zDarshan et al., 2009
GRX5/GRX5 N.D. Hypochromic anemiaA AWingert et al., 2005
HD/Huntingtin N.D. *Hypochromic anemiaB BLumsden et al., 2007
BDH2/2,5-DHBA N.D. *Hypochromic anemiaC CDevireddy et al., 2010
ARHGEF3/ARHGEF3 N.D. *Hypochromic anemiaD DSerbanovic-Canic et al., 2011
*Knockdown (KD) model.
hemoglobin level in weh mutants can be rescued by intravenous
iron-dextran injections, demonstrating that their hypochromia is
caused by inadequate iron in the blood (Donovan et al., 2000). To
identify the precise location of the gene mutation, chromosomal
walking was performed and revealed a premature stop codon in
a novel gene named ferroportin1 (fpn1), consistent with a loss-of-
function mutation. Importantly, overexpressing fpn1 in mutant
embryos rescued the hypochromia phenotype, suggesting that the
fpn1 gene is causally linked to the disease. Fpn1 transcripts are
present specifically in the zebrafish yolk syncytial layer (YSL),
between the developing hematopoietic cells in the intermediate
cell mass and the yolk, which contains iron and other nutrients
essential for early embryonic development. This specific expres-
sion pattern of fpn1, together with the iron-deficiency phenotypes
observed in weh mutants, suggests that the function of the fpn1
protein is to export iron from the yolk into the embryonic circula-
tion. This hypothesis was confirmed by performing an iron efflux
assay in a Xenopus oocyte expression system, in which oocytes
expressing fpn1 had increased iron efflux (Donovan et al., 2000).
Moreover, both mice and humans have homologs of FPN1 that
are highly conserved with the fish fpn1, and mammalian FPN1
is robustly expressed in the placenta, duodenum, and liver, all
of which are major sites of iron transport. At the protein level,
human FPN1 is concentrated at the basal surface of the syn-
cytiotrophoblasts in the placenta, an organ that is functionally
similar to the zebrafish YSL, indicating that human FPN1 plays
a role in maternal-fetal iron export. In mice, Fpn1 is expressed
at the basolateral surface of enterocytes, suggesting a role as an
intestinal iron transporter (Donovan et al., 2000). This study
serves as a prime example as how genetic screens in zebrafish can
lead to the identification of essential novel genes. Nevertheless,
Fpn1 remains the only iron exporter that has been identified in
all eukaryotic organisms.
Shortly after these findings in the zebrafish weh mutants
were reported (Donovan et al., 2000), two groups independently
cloned Fpn1 (also called Ireg1 or Mtp1) from mouse duodenal
epithelial cells and a mouse mRNA library (Abboud and Haile,
2000; McKie et al., 2000). Both studies confirmed the essential
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role of Fpn1 in iron export and the regulation of iron homeosta-
sis. Mutations in SLC11A3, the human homolog of FPN1, were
later identified as causing autosomal dominant hemochromato-
sis, a disorder characterized by iron overload and multiple organ
damage (Montosi et al., 2001; Njajou et al., 2001).
The effect of Fpn1 deficiency on the adult zebrafish system
was examined in further detail. Although weh homozygotes are
embryonic lethal and usually die 7–14 days post-fertilization
(dpf), repeated intravenous injections of iron-dextran enables the
mutants to reach adulthood (Donovan et al., 2000; Fraenkel et al.,
2005). These rescued fish are normal until 6 months of age, but
develop hypochromic blood by 12 months. Compared with iron-
injected wild-type fish, the rescued mutants had increased iron
staining in the kidney macrophages at 12 months of age, as well
as increased staining in the intestinal villi at 6 and 12 months,
suggesting that the fpn1 mutation impairs iron export in these
tissues. The iron-rescued weh mutants also has hepatic iron over-
load, with particularly high iron levels in the liver Kupffer cells
(Fraenkel et al., 2005). The role of Fpn1 in iron mobilization
from enterocytes, hepatocytes, and macrophages was confirmed
by studies using adult tissue-specific Fpn1 knockout mice (Zhang
et al., 2011, 2012). Hepcidin, a peptide hormone secreted by the
liver, was found to regulate iron by triggering the internalization
of Fpn1 and inhibiting iron efflux (Nemeth et al., 2004). Hepcidin
is also conserved in fish, and injecting zebrafish embryos with iron
causes a significant increase in endogenous hepcidin expression.
Moreover, a similar iron-stimulated increase in hepcidin expres-
sion occurs in weh mutant embryos, suggesting that hepcidin
expression is independent of Fpn1’s normal function as an iron
exporter (Fraenkel et al., 2005).
Dmt1
The protein DMT1 (also called DCT1 and Nramp2), which con-
tains 12 transmembrane domains, was originally isolated in the
rat duodenum as a divalent ion transporter that is upregulated
by dietary iron deficiency (Gunshin et al., 1997). Shortly after
its discovery, two mammalian hypochromic anemia models—
the mk/mk mouse and the Belgrade rat—were found to carry
DMT1 mutations (Fleming et al., 1997, 1998). The chardon-
nay (cdy) zebrafish mutant revealed a conserved role of DMT1
in zebrafish iron metabolism (Donovan et al., 2002). The cdy
mutant is a hypochromic, microcytic anemia model with reduced
hemoglobin expression and delayed erythrocyte maturation. The
cdy mutant has a premature stop codon in the zebrafish homolog
of dmt1, resulting in a severely truncated protein. The zebrafish
homolog of DMT1 is 73% identical to human and mouse DMT1
homologs, and its transcripts are concentrated both in erythroid
cells and in the intestine. Direct evidence of the role of zebrafish
DMT1 in iron transport came from experiments using a mam-
malian cell line; cells that overexpressed wild-type zebrafish dmt1
took up nearly 10 times the amount of iron as non-transfected
control cells, whereas the truncated protein produced by the
cdy mutation was non-functional. Interestingly, unlike the weh
mutants, which die during early development (Donovan et al.,
2000), the anemic cdy homozygotes survive and reach adult-
hood. The viability of cdy fish may be attributed to additional
pathways for iron absorption (Donovan et al., 2002). Of clinical
relevance, the first identified human mutation in DMT1 was
reported to cause symptoms that include severe hypochromic
microcytic anemia and iron overload (Mims et al., 2005). One
possible explanation for the excess iron in these patients is the
presence of an alternate iron absorption route in the duodenum,
thereby bypassing DMT1 (Mims et al., 2005).
Tfr1
Transferrin receptor 1 (Tfr1) is a membrane-bound protein that
facilitates iron uptake by binding to the iron carrier Transferrin.
Tfr1 was identified as being essential for erythropoiesis and
embryonic development in a Tfr1-knockout mouse model (Levy
et al., 1999). Tfr1−/− mice develop anemia, have retarded growth
and neurological defects, and die during embryogenesis (Levy
et al., 1999). Four different zebrafish chianti (cia) mutants were
identified with various degrees of hypochromic anemia and
defective erythroid differentiation (Haffter et al., 1996; Wingert
et al., 2004), and positional cloning revealed that cia alleles
are missense and splicing mutations. During early develop-
ment, tfr1a transcripts are expressed specifically in erythrocytes.
Importantly, cytoplasmic delivery of iron by microinjection at
the 1-cell stage—but not intravenous iron injections—can res-
cue the hypochromia phenotypes of cia mutants, indicating that
the tfr1a mutation prevents erythrocytes from taking up and uti-
lizing circulating iron (Wingert et al., 2004). Interestingly, while
cloning tfr1a, a second tfr1-like gene, tfr1b, was also identified
(Wingert et al., 2004). This gene duplication phenomenon in
zebrafish is believed to have occurred as an evolutionary genetic
event in teleosts (Amores et al., 1998; Postlethwait et al., 1998).
The tfr1b gene is expressed ubiquitously throughout embryo-
genesis. Notably, although overexpressing tfr1b partially rescues
the anemic phenotypes of cia mutants, tfr1b morphants (animals
in which the gene has been knocked down by injecting mor-
pholino antisense oligonucleotides) have normal hemoglobiniza-
tion. Nevertheless, tfr1b morphants have retarded growth and
develop brain necrosis, a phenotype that is similar to the neu-
rologic defects observed in the mouse model (Levy et al., 1999),
indicating that tfr1b may be involved in iron uptake through
non-erythroid tissues (Wingert et al., 2004). Thus, the combined
phenotypes of tfr1a and tfr1b deficient zebrafish embryos appear
to recapitulate the entire phenotypic spectrum of Tfr1−/− mice.
Therefore, the ciamutant zebrafish is an ideal model for studying
the function of tfr1 in erythropoiesis without the complication of
other developmental abnormalities.
Grx5
The shiraz (sir) zebrafish mutants were originally isolated from
the Tübingen 2000 screen consortium; these mutants were later
identified as a typical hypochromic anemia disease model with
a deletion in the glutaredoxin 5 (grx5) gene which encodes an
antioxidant protein (Wingert et al., 2005). Functional studies
of grx5 in sir zebrafish revealed a novel connection between
heme biosynthesis and iron-sulfur (Fe-S) cluster formation, two
primary functions of iron that were previously believed to be
independent processes in vertebrates.
Studies in yeast revealed that GRX5 is required for the mito-
chondrial synthesis of Fe-S clusters (Rodriguez-Manzaneque
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et al., 2002). Similar to the yeast GRX5, zebrafish grx5 is also
localized primarily in the mitochondria, and expression of the
zebrafish grx5 gene can rescue a GRX5-deficient yeast strain,
suggesting that the function of grx5 is evolutionarily conserved.
However, the sir zebrafish mutants have a hypochromic ane-
mia phenotype, with no changes in their mitochondrial iron
content or oxidative stress level (Wingert et al., 2005). With
respect to iron metabolism, one key difference between yeast
and higher eukaryotes is that in the latter, iron regulatory pro-
teins 1 and 2 (IRP1/2) control intracellular iron levels by binding
to Iron Response Elements (IREs) in the 5′-UTR of target gene
transcripts, thereby blocking their translation. Importantly, the
IRE-binding capacity of IRP1 is negatively regulated by Fe-S
clusters. Thus, a possible explanation for the anemic pheno-
type in sir zebrafish mutants is that the grx5 mutation reduces
Fe-S assembly, inappropriately triggering IRP1 activity, which
then inhibits the expression of select target genes that are crit-
ical for heme biosynthesis. In support of this hypothesis, red
blood cells in sir zebrafish mutants lack aminolevulinate syn-
thase 2 (ALAS2), the first enzyme in the heme biosynthesis
pathway. Moreover, overexpressing an ALAS2 gene in which the
IRE is deleted rescues hemoglobin production in sir mutants; in
contrast, overexpressing the wild-type ALAS2 gene does not res-
cue hemoglobin production. Interestingly, knocking down the
expression of IRP1 also rescues the sir embryonic phenotype.
These compelling results strongly suggest that heme synthesis
in vertebrates is regulated via Fe-S cluster levels (Wingert et al.,
2005). A conserved role for GRX5 in regulating heme synthesis
was additionally confirmed in human patients (Camaschella et al.,
2007). The findings obtained from sir mutants serve to highlight
the advantages of using zebrafish as a vertebrate model system
for discovering mechanisms that are not necessarily conserved in
lower organisms.
Mitoferrin
The role of Mitoferrin (Mfrn) in mitochondrial iron uptake was
originally discovered in yeast studies (Foury and Roganti, 2002).
MRS3 and MRS4, the yeast homologs of Mfrn, increase the
efficiencies of both heme formation and Fe-S biosynthesis, the
two key mitochondrial processes that utilize iron (Muhlenhoff
et al., 2003). Studies of frascati (frs) zebrafish mutants further
support Mfrn’s role as a principal mitochondrial iron importer
in vertebrate erythroblasts. Frs mutants develop defects such
as hypochromic anemia and erythroid maturation arrest (Shaw
et al., 2006), and positional cloning identified missense mutations
in the mfrn gene in all mutant lines. Importantly, overexpressing
mfrn in frs mutants rescued the erythropoiesis deficiency in half
of the injected animals, and mfrn knockdown morphants mim-
icked the mutant phenotype, suggesting that mfrn is the disease-
causing gene in frs mutants. Expression array analysis revealed
that mfrn is highly expressed in the intermediate cell mass (the
tissue in which erythropoiesis occurs for early embryos), further
supporting mfrn’s role in erythroid heme synthesis. Similar to
yeastMRS3/4, when overexpressed in transfected mammalian cell
lines, zebrafish mfrn localizes to the mitochondria (Shaw et al.,
2006). To investigate the function of mammalian Mfrn further,
anMfrn−/− mouse hematopoietic cell line was established. These
cells have impaired terminal erythroid maturation and an inabil-
ity to incorporate iron into heme proteins. Furthermore, mouse
Mfrn rescues the phenotype in zebrafish frsmutants, and fishmfrn
restores the activity of an MRS3/4-deficient yeast strain (Shaw
et al., 2006). Taken together, these results suggest that Mfrn’s role
in mitochondrial iron uptake is evolutionarily conserved among
eukaryotes.
Transferrin-a
Zebrafish gav mutant strains carry mutations in their transferrin-
a (tf-a) gene, which encodes the principal iron carrier in all
vertebrate organisms (Fraenkel et al., 2009).Gavmutants develop
severe hypochromic anemia. Importantly, this phenotype can be
phenocopied by injecting tf-a morpholinos into embryos, and it
can be rescued by overexpressing tf-a. Together, these findings
confirm that tf-a is the disease-causing gene. Homozygous gav
mutants are generally embryonic lethal and die at approximately
14 dpf (Fraenkel et al., 2009). In humans, genetic mutations
in transferrin cause congenital hypotransferrinemia, a rare dis-
ease with features that are strikingly similar to the phenotype
in gav fish, including hypochromic anemia and premature death
(Hayashi et al., 1993; Goldwurm et al., 2000). Thus, the zebrafish
gav mutant serves as an ideal model for studying human hypo-
transferrinemia. In addition, Fraenkel and colleagues examined
hepcidin expression in the gav mutant, as well as several previ-
ously established zebrafish mutants with iron metabolism defects.
In 2-dpf zebrafish embryos (the stage in which endogenous hep-
cidin expression is least affected by environmental stimuli), the
number of hepcidin transcripts was measured in various mutants
and morphants either with or without iron injection. The results
suggest that both tf-a and tfR2 are required for hepcidin expres-
sion, whereas tfR1a and dmt1 are required for increasing hepcidin
expression in response to iron loading (Fraenkel et al., 2009).
The primary role of Tf in driving hepcidin expression is fur-
ther supported by studies performed using a mouse model of
hypotransferrinemia (Bartnikas et al., 2011).
ZEBRAFISH AS A REVERSE GENETICS TOOL IN IRON METABOLISM
STUDIES
In addition to helping identify novel iron transporters and
metabolic mechanisms via forward genetic screens, zebrafish have
also been used as a reverse genetics tool for increasing our
understanding of the iron homeostasis system.
Gene knockdown/knockout
Gene knockdown/knockout techniques are used as a primary
step in investigating the unknown biological functions of a given
gene. In this approach, antisense morpholino oligonucleotides
bind to the targeted gene transcript, thereby inhibiting the gene’s
expression by blocking the initiation of translation or by mod-
ifying pre-mRNA splicing. Because zebrafish develop ex utero,
microinjection-mediated gene suppression is used widely among
zebrafish researchers.
Hd. Studies performed using hd zebrafish morphants revealed a
novel role for Huntingtin (Htt, a protein linked to Huntington’s
disease) in the utilization of iron by erythrocytes (Lumsden
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et al., 2007). Although it has been known for more than two
decades that Huntington’s patients carry an expanded CAG
repeat in the coding region of the HD gene (Huntington’s
Disease Collaborative Research Group, 1993), the normal func-
tion of Htt remains unclear. In order to explore the biological
roles of HD, hd knockdown morphant zebrafish were created
(Lumsden et al., 2007). Interestingly, in addition to neurologi-
cal defects such as brain necrosis, the hd knockdown fish also
develop blood hypochromia (characterized by reduced red pig-
ments in the erythrocytes) and decreased hemoglobin staining.
Nevertheless, Prussian blue staining revealed that hd morphants
have normal iron levels in their red blood cells, suggesting that
Tf-Tfr–mediated iron transport and endocytosis are intact in
the erythrocytes. Intriguingly, Prussian blue only stains ferric
iron that is bound to Tf, but does not stain ferrous iron in
hemoglobin. Thus, the hypochromia observed in the hd mor-
phants is likely due to defects that are downstream of Tf-Tfr
endocytosis. This hypothesis was tested by injecting iron-dextran
directly into the cytoplasm at the 1-cell stage, which circum-
vents the Tf-Tfr–mediated iron cycle. Using this approach, the
hypochromia defects in hd morphants were largely rescued
(Lumsden et al., 2007). This important study revealed an inter-
esting role for Htt in making endocytosed iron available for use
by the cell; however, the detailed mechanism by which Htt regu-
lates iron release and/or downstream utilization must be explored
further.
Bdh2. Although the vast majority of intracellular iron is bound
by proteins, a small amount of cytoplasmic iron is bound to
low-molecular-weight carriers called siderophores, forming a
labile iron pool (Breuer et al., 2008). Enterobactin is a classic
bacterial siderophore that binds to Lipocalin 24p3, an iron-
trafficking protein that functions as the iron-chelating moiety
(Yang et al., 2002). In mouse cell cultures, 2,5-dihydroxybenzoic
acid (2,5-DHBA) is the iron-bindingmoiety of the 24p-associated
mammalian siderophore, the synthesis of which is catalyzed
by 3-hydroxybutyrate dehydrogenase type 2 (Bdh2), a dehy-
drogenase/reductase family member (Devireddy et al., 2010).
In Bdh2-knockdown mouse cells, the intracellular siderophore
was depleted, and the cells accumulated abnormally high
amounts of free cytoplasmic iron, resulting in elevated levels
of ROS. Notably, these cells were also deficient in mitochon-
drial iron, suggesting that siderophores also participate in the
transport of iron from the cytoplasm to the mitochondria.
Importantly, bdh2 zebrafish morphants develop hypochromic
blood and have reduced hemoglobin levels—but normal globin
expression—confirming a defect in mitochondrial heme syn-
thesis (Devireddy et al., 2010). These findings demonstrate
that the function of siderophores in regulating intracellular
iron homeostasis is conserved from bacteria to vertebrates. In
this respect, zebrafish are a convenient model for confirming
and extending findings obtained from studying mammalian cell
cultures.
Arhgef3. Genome-wide association and meta-analysis studies
have identified more than 100 independent genetic loci asso-
ciated with erythrocytes and platelets (Ganesh et al., 2009;
Soranzo et al., 2009). Because of its advantages with respect
to reverse genetics, the zebrafish model was used to investigate
the biological functions of several candidates identified from the
meta-analysis. This screen revealed that Rho guanine nucleotide
exchange factor 3 (Arhgef3) plays an unexpected role in regulating
iron uptake and driving erythroid cell maturation (Serbanovic-
Canic et al., 2011). Silencing arhgef3 expression in zebrafish
disrupts erythroid differentiation and causes hypochromic ery-
throcytes, which are indicative of iron-deficiency anemia. Indeed,
cytoplasmic iron supplementation significantly rescues the
hemoglobinization phenotype in arhgef3 morphants. Moreover,
disrupting the arhgef3 target RhoA produces a phenotype that
is similar to arhgef3 morphants, and this can also be rescued by
cytoplasmic iron injection. The concerted roles of Arhgef3 and
RhoA in regulating the internalization of membrane-bound Tf
was supported by studies in a human cell line (Serbanovic-Canic
et al., 2011).
In vivo validation of cis-regulatory elements in mfrn1 using
transgenic fish. In erythroblasts, Mfrn1, and Mfrn2 are solute
carriers that import cytoplasmic iron into the mitochondria for
heme and Fe-S cluster biogenesis (Shaw et al., 2006; Paradkar
et al., 2009). In mice, both the Mfrn1 and Mfrn2 genes contain
CpG-rich promoter regions. The cis-regulatory modules (CRMs)
in Mfrn1 form a chromatin immunoprecipitation dataset for
GATA-1, the primary erythroid transcription factor (Cantor and
Orkin, 2002), suggesting that Mfrn1 is transcriptionally regulated
by GATA-1 via binding at CRM regions. Though quite com-
pelling, these bioinformatics results still needed to be validated
functionally at the systemic level, and transgenic fish were a con-
venient tool for this purpose. Mfrn1 transcripts are concentrated
primarily in hematopoietic tissues, whereas mfrn2 transcripts are
expressed throughout the central nervous system and in somites
(Shaw et al., 2006). Transgenic zebrafish expressing GFP-tagged
mouse Mfrn1 or Mfrn2 promoter sequences were generated to
study the expression of these genes. When expressed in fish, the
Mfrn2 promoter is expressed in a pattern similar to the endoge-
nous mfrn2 expression pattern, suggesting that the promoter
functions appropriately. However, the tagged Mfrn1 promoter
failed to drive detectable GFP expression in fish, suggesting the
need for other transcriptional regulatory elements (Amigo et al.,
2011). Interestingly, injecting two of the three predicted mouse
Mfrn1 CRMs yielded transient transgenic fish that expressed GFP
in the same tissues as endogenous mfrn1. The specific expression
pattern was refined further in transgenic fish carrying a con-
struct that contains a CRM linked with the CpG-rich promoter.
Thus, the critical role of CRMs in regulating Mfrn1 expression
has been demonstrated in vivo (Amigo et al., 2011). Moreover,
the critical role for GATA-1 in regulating Mfrn1 transcription
was confirmed by the finding that the Mfrn1-specific expres-
sion pattern was abolished after the GATA-1 core binding sites
were mutated in the CRMs of the transgenic fish. Finally, the
expression of endogenous mfrn1 was also markedly reduced in
GATA-1 zebrafish morphants (Amigo et al., 2011). This semi-
nal study supports the high value of using zebrafish transgenics
to complement and validate findings obtained from in silico
analyses.
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Gene overexpression
The ex utero development of zebrafish also enables researchers to
drive gene overexpression through microinjection. Importantly,
the biological mechanisms that underlie dominant-negative gene
mutations inmammals can be examined readily in zebrafish using
gene overexpression techniques. In humans, FPN1 mutations
have been linked to a form of autosomal dominant hemochro-
matosis (Pietrangelo, 2004). Interestingly, two distinct clinical
phenotypes have been characterized: one phenotype includes
iron accumulation in macrophages, low transferrin saturation,
and iron-limited erythropoiesis, whereas the other phenotype
includes iron accumulation in hepatocytes and high transferrin
saturation. The diversity of these clinical traits can be explained
by the different natures of the underlying FPN1 mutations (De
Domenico et al., 2006). Mutations that cause a defect in FPN1’s
cell-surface localization or iron export capacity cause iron loading
in macrophages, whereas mutations that impair FPN1’s sensitiv-
ity to Hepcidin (thus impeding FPN1 incorporation) cause iron
accumulation in hepatocytes (De Domenico et al., 2005, 2006;
Schimanski et al., 2005). Nevertheless, the clinical complexity of
the long-term disease process makes it difficult to determine the
precise nature of a given FPN1 mutation. Overexpressing mutant
FPN1 alleles in zebrafish is a high-throughput approach for iden-
tifying the functional effects of many mutations (De Domenico
et al., 2007). The cDNA of wild-type mouse Fpn1 or previously
identified human and mice Fpn1 mutants was injected into 1-
cell stage zebrafish embryos. Expressing either wild-type Fpn1
or the N144H Fpn1 mutant (a Hepcidin-irresponsive protein)
had no effect on endogenous hemoglobinization. However, over-
expressing the H32R Fpn1 mutant (which has defective Fpn1
membrane localization) or the N174I Fpn1 mutant (which is
transport-deficient) led to severe defects in hemoglobin synthesis,
and these hemoglobinization defects were rescued by intravenous
iron injections, suggesting the existence of iron-deficiency ery-
thropoiesis in these mutant-expressing embryos (De Domenico
et al., 2007). This study demonstrates nicely that the functional
consequences of mammalian Fpn1 mutations can be studied
rapidly and effectively, and it supports the important role of
zebrafish as a valuable vertebrate model in functional studies of
dominant-negative mutations.
ZEBRAFISH AND ZINC METABOLISM
OVERVIEW OF ZINC METABOLISM
After iron, zinc is the second-most abundant trace mineral in
humans. Zinc is essential for the activity of more than 300
enzymes and for maintaining the structural integrity of nearly
2000 transcription factors. Thus, zinc plays a critical role in cellu-
lar homeostasis, the immune response, oxidative stress, apoptosis,
and aging (Stefanidou et al., 2006; Prasad, 2012). Zinc defi-
ciency can cause a wide range of clinical defects, including growth
retardation, hypogonadism, rough skin, weakened immunity, and
neurosensory and cognitive disorders (Prasad, 2012). Although
zinc is a redox-inactive metal, it can be toxic (albeit less toxic than
iron and copper), and both acute and chronic forms of zinc poi-
soning have been reported to cause hematopoietic abnormalities,
altered lipoprotein metabolism, and impaired immune function
(Stefanidou et al., 2006).
In vivo, zinc homeostasis relies primarily on the zinc trans-
porter family, which in mammals contains 10 Zinc Transporter
proteins (ZnTs, or SLC30) and 14 Zrt- and Irt-like proteins (ZIPs,
or SLC39) (Huang and Tepaamorndech, 2013; Jeong and Eide,
2013). ZnTs are zinc exporters that facilitate the efflux of zinc
from cells and/or into intracellular vesicles, whereas ZIPs increase
intracellular zinc concentration by driving the uptake of extracel-
lular zinc and/or the release of vesicular zinc into the cytoplasm.
The concerted actions of ZnTs and ZIPs maintain the balance
of intracellular zinc and deliver zinc to its appropriate protein
partners (Figure 2). Metallothioneins (MTs) are a group of low-
molecular-weight metal-binding proteins that also have a high
affinity for binding zinc. MTs play an important regulatory role in
zinc metabolism, possibly by competing with—or supplying zinc
to—a variety of transporter proteins (Vasak and Hasler, 2000;
Chasapis et al., 2012).
ZINC HOMEOSTASIS IS HIGHLY CONSERVED BETWEEN ZEBRAFISH
AND MAMMALS
The system that regulates zinc metabolism is highly conserved
between zebrafish and mammals. The zebrafish zip1 gene was
cloned from the zebrafish gill, an ion-transporting epithelium
that absorbs minerals from the surrounding water (Qiu et al.,
2005). The Zip1 protein is conserved both structurally and func-
tionally with its mammalian homologs. Zip1 transcripts are
expressed ubiquitously in zebrafish embryos, with the highest
expression in the ovaries. As with human ZIP1 (Gaither and Eide,
2001), overexpressing zebrafish zip1 significantly increases zinc
uptake. Interestingly, because Zip1 does not increase zinc influx
at high extracellular zinc concentrations, it has no effect on the
maximum endogenous rate of zinc uptake (Qiu et al., 2005).
This ceiling effect might be due to the fact that zinc regulates
the cellular localization of Zip1. Studies in mice suggest that the
extracellular zinc concentration mediates the cellular localization
of Zip1 through an endocytosis-mediated pathway (Wang et al.,
2004). A second zinc importer in teleosts, zip2, was cloned from
the gill of a pufferfish species (Takifugu rubripes) and plays a role
in mediating zinc uptake (Qiu and Hogstrand, 2005).
A systematic bioinformatics data-mining approach identi-
fied the zebrafish zinc transporter genes from two previously
released zebrafish databases (Zv4 Ensembl 31 and Zv5 Ensembl
34), and these genes were phylogenetically assigned to mam-
malian orthologs (Feeney et al., 2005). To date, eight ZnT mem-
bers (ZnT1, ZnT2, and ZnT4–9) and 11 ZIP members (ZIP1,
ZIP3, ZIP4, ZIP6–11, ZIP13, and ZIP14) have been identified
in zebrafish. Interestingly, the teleost ZIP8 sequence differs from
mammalian ZIP8 orthologs to a larger degree than other ZIP
genes. Studies of gene expression patterns revealed that the
ovaries and intestine—the two organs that have themost dynamic
nutrient metabolism—have the highest expression of zinc trans-
porters (Feeney et al., 2005). The expression level of each zinc
transporter has been examined during zebrafish embryogene-
sis under normal maternal zinc conditions (Ho et al., 2012).
The results showed that despite a relatively constant level of
endogenous zinc during embryonic development from fertiliza-
tion through 120 h post-fertilization (hpf), zinc transporters are
differentially expressed throughout this period. Nearly all zinc
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FIGURE 2 | Generalized overview of zinc metabolism in vertebrate cells.
Zinc Transporters (ZnTs) downregulate intracellular zinc levels by exporting
zinc through the plasma membrane (ZnT1, ZnT2, and ZnT4) or by transporting
zinc into various intracellular compartments, including lysosomes (ZnT2), the
Golgi apparatus (ZnT5-7), mammary gland vesicles (ZnT2 and ZnT4), insulin
granules (ZnT8), and synaptic vesicles (ZnT3). In addition, ZnT9 can
translocate to the nucleus, where it regulates target gene transcription. Zrt-
and Irt-like proteins (ZIPs) upregulate cytoplasmic zinc levels by importing
extracellular zinc (ZIP1–6, ZIP8, ZIP10, and ZIP14) and release zinc from
intracellular vesicles (ZIP1 and ZIP13), lysosomes (ZIP3 and ZIP8), the Golgi
apparatus (ZIP7, ZIP9, and ZIP13) and the nucleus (ZIP7). Proteins for which
zebrafish knockout/knockdown models are available are written in red.
transporters have their highest expression at 120 hpf, with the
exception of ZNT8, which peaks at 48 hpf (Ho et al., 2012).
The release of the latest zebrafish database (Zv9 Ensembl 73)
has further increased our knowledge of zebrafish genome, con-
firming the existence of zebrafish ZNT10 and ZIP5 in zebrafish.
The homology of zinc transporters among zebrafish, mice and
humans is summarized in Table 3. An influence of Zn on the
uptake and circulatory influx of Cd has been reported in fish, sug-
gesting that the uptake of Zn and Cd occurs through common
pathways (Wicklund Glynn, 2001).
ZEBRAFISH MODELS OF ZINC METABOLISM
The current zebrafish and mouse models available for studying
zinc metabolism are listed in Table 4.
Zip6
Zip6 is a member of the LIV-1 subfamily of ZIP zinc trans-
porters, which in humans consists of nine ZIP members that
contain a highly conserved metalloprotease motif. Importantly,
LIV-1 is regulated by estrogen and has been implicated in
metastatic breast cancer (Taylor, 2000), although how LIV-1
mediates cancer metastasis is unclear. Studies using Zip6 (LIV1)
zebrafish morphants have been instrumental in addressing this
problem (Yamashita et al., 2004); the zebrafish zip6 cDNA was
cloned by subtraction screening. Interestingly, the expression
pattern of endogenous zip6 mimics the expression of stat3, an
important player in the epithelial-mesenchymal transition (EMT)
during gastrulation, organogenesis, wound-healing, and cancer
progression (Sano et al., 1999; Yamashita et al., 2002). Notably,
the expression of zip6 is abolished in stat3 zebrafish morphants,
suggesting that zip6 is downstream of stat3. The ability of stat3
to transcriptionally regulate zip6 was confirmed in studies using
mouse and human cell lines (Yamashita et al., 2004). The role
of zip6 in early embryonic development was assessed further
in zip6-depleted zebrafish embryos. By the end of gastrulation,
these zip6 morphants have malpositioned heads and a short-
ened anterior-posterior axis, although early cell-fate specification
was not affected, suggesting that zip6 plays a critical role in
cell migration during gastrulation. Cell tracing and cell trans-
plantation assays further support the cell-autonomous role of
Zip6 in the migration of mesendodermal cells (Yamashita et al.,
2004). Phenotypic analyses of zip6 morphants revealed that cell-
cell adhesion was not downregulated as occurs normally, thus
resulting in severe perturbations in cell migration. These same
defects were also observed in zebrafish morphants in which the
zinc-finger protein Snail, a master regulator of EMT, is knocked
down (Batlle et al., 2000; Cano et al., 2000). Moreover, the in vivo
activity of Zip6 is dependent on Snail; Zip6 regulates the nuclear
translocation of Snail (Yamashita et al., 2004). This was the first
study to use multiple zebrafish knockdown models to establish a
molecular link between Stat3, Zip6, and Snail during EMT.
Zip7
Zip7 is also a member of the LIV-1 subfamily of zinc trans-
porters. Studies using mammalian cell lines suggest that human
ZIP7 plays a role in elevating cytoplasmic zinc concentrations
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Table 3 | Zinc metabolism–related proteins in zebrafish, mice, and humans.
Gene/Protein Function/Related diseases Tissue distribution Protein identity
(vs. H)
M% Z%
SLC30A1/ZNT1 Plasma Zn exporter/N.D. H Ubiquitous 86 61a/54b
M Ubiquitous
Z N.D.
SLC30A2/ZNT2 Plasma Zn exporter, transport Zn into mammary
gland vesicles/Transient neonatal Zn deficiency
H Ubiquitous 79 N.D.
M Adipose, placenta, intestine, prostate,
pancreas, kidney, testis, mammary gland
Z Hindbrain, neurons, spinal cord
SLC30A3/ZNT3 Transport Zn into synaptic vesicles/N.D. H Ubiquitous 89 N.D.
M Amygdala, cerebral cortex, hippocampus,
spinal cord, testis, pancreas
Z N.D.
SLC30A4/ZNT4 Plasma Zn exporter, transport Zn into mammary
gland vesicles/Zn deficiency in milk
H Ubiquitous 92 53
M Lacrimal gland, mammary gland, placenta,
intestine
Z N.D.
SLC30A5/ZNT5 Plasma Zn exporter, transport Zn into Golgi/N.D. H Ubiquitous 95 78
M Ubiquitous
Z Ubiquitous
SLC30A6/ZNT6 Transport Zn into Golgi/N.D. H Ubiquitous 91 12
M Ubiquitous
Z Ubiquitous
SLC30A7 /ZNT7 Transport Zn into Golgi/N.D. H Ubiquitous 96 79
M Ubiquitous
Z CNS, notochord
SLC30A8/ZNT8 Transport Zn into insulin granules/Diabetes mellitus H Pancreatic islet 81 53
M Ubiquitous
Z Ubiquitous
SLC30A9/ZNT9 Plasma Zn exporter, transcriptional regulation in
nucleus/N.D.
H Ubiquitous 89 73
M Ubiquitous
Z Ubiquitous
SLC30A10/ZNT10 Cation transporter/Hypermanganesemia with
dystonia, polycythemia, and cirrhosis
H Ubiquitous 80 46
M Stomach, intestine, prostate, liver,
amygdala, cerebral cortex
Z N.D.
SLC39A1/ZIP1 Plasma Zn importer, Zn release from vesicles/N.D. H Ubiquitous 94 N.D.
M Ubiquitous
Z Brain, eye, gill, heart, integument, kidney,
musculature system, neural crest, ovary
SLC39A2/ZIP2 Plasma Zn importer/N.D. H Ubiquitous 78 N.D.
M Ubiquitous
Z N.D.
SLC39A3/ZIP3 Plasma Zn importer, Zn release from lysosomes/N.D. H Ubiquitous 84 N.D.
M Ubiquitous
Z Ubiquitous
(Continued)
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Table 3 | Continued
Gene/Protein Function/Related diseases Tissue distribution Protein identity
(vs. H)
M% Z%
SLC39A4/ZIP4 Plasma Zn importer/acrodermatitis enteropathica H Ubiquitous 72 N.D.
M Lung, placenta, uterus, ovary, stomach,
intestine, liver
Z Ubiquitous
SLC39A5/ZIP5 Plasma Zn importer/N.D. H N.D. 84 37
M Pancreas, intestine, stomach, placenta,
kidney
Z N.D.
SLC39A6/ZIP6 Plasma Zn importer/N.D. H Ubiquitous 88 43
M Ubiquitous
Z N.D.
SLC39A7 /ZIP7 Zn release from Golgi and the nucleus/N.D. H Ubiquitous 87 54
M Ubiquitous
Z Brain, eye, forebrain, gill, muscle, optic
cup, retina
SLC39A8/ZIP8 Plasma Zn importer at the onset of inflammation/N.D. H Ubiquitous 89 54
M Ubiquitous
Z Ubiquitous
SLC39A9/ZIP9 Zn release from Golgi/N.D. H Ubiquitous 93 82
M Ubiquitous
Z Ubiquitous
SLC39A10/ZIP10 Plasma Zn importer / N.D. H Ubiquitous 87 47
M Ubiquitous
Z Anterior axial hypoblast, gill, hatching
gland, kidney, pigment cells, polster
SLC39A11/ZIP11 Cation transport/N.D. H Ubiquitous 89 67
M Ubiquitous
Z Ubiquitous
SLC39A12/ZIP12 Cation transport / N.D. H Ubiquitous 78 N.D.
M Spinal cord, hypothalamus, retinal
pigment, ciliary bodies
Z N.D.
SLC39A13/ZIP13 Zn release from Golgi and vesicles/Ehlers-Danlos
syndrome-like spondylocheirodysplasia
H Ubiquitous 91 53
M Ubiquitous
Z Ubiquitous
SLC39A14/ZIP14 Plasma Zn importer/N.D. H Smooth muscle, pancreas islet, liver, lung,
intestine
83 67
M Ubiquitous
Z Notochord, olfactory placode, otic placode,
presumptive telencephalon, somite
aslc30a1a.
bslc30a1b.
H, human; M, mouse; Z, zebrafish; N.D., not determined; CNS, central nervous system.
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Table 4 | Zinc metabolism–related mouse and zebrafish knockout/knockdown models and their phenotypes.
Gene/Protein KO mouse models KO/KD zebrafish models References
SLC30A1/Znt1 Embryonic lethalitya N.D aAndrews et al., 2004
SLC30A3/Znt3 Age-dependent deficits in learning and
memoryb,c
N.D bCole et al., 1999; cAdlard et al., 2010
SLC30A4/Znt4 Zinc-deficient milk, otolith degeneration,
impaired motor coordination, alopecia,
dermatitisd
N.D dHuang and Gitschier, 1997
SLC30A5/Znt5 Growth retarded, skeletal defectse N.D eInoue et al., 2002
SLC30A7/Znt7 Reduction in body fat accumulationf N.D fHuang et al., 2007
SLC30A8/Znt8 Reduced islet zinc levels, circulating insulin
levels, and glucose stimulated insulin
secretiong,h
N.D gNicolson et al., 2009; hPound et al., 2009
SLC39A1/Zip1 Abnormal developmenti N.D iDufner-Beattie et al., 2006
SLC39A2/Zip2 Retarded growthj N.D jPeters et al., 2007
SLC39A3/Zip3 No obvious abnormalitiesk N.D kDufner-Beattie et al., 2005
SLC39A4/Zip4 Embryonic lethalityl,m N.D lDufner-Beattie et al., 2007; mGeiser et al., 2012
SLC39A6/Zip6 N.D *Embryonic lethality, shortened
anterior-posterior axisn
nYamashita et al., 2004
SLC39A7/Zip7 N.D *Embryonic lethality, curved
notochord, reduced eye sizeo
oYan et al., 2012
SLC39A13/Zip13 Skeletal abnormalities and dental
abnormalitiesp
N.D pFukada et al., 2008
SLC39A14/Zip14 Decreased body size, torticollis, reduced
bone volume, scoliosis, impaired fasting
gluconeogenesis, decreased hepatic zinc
levelq,r
N.D qHojyo et al., 2011; rBeker Aydemir et al., 2012
*Knockdown (KD) model.
by transporting zinc from the Golgi apparatus to the cytoplasm
(Huang et al., 2005b). The systemic expression and function of
Zip7 was examined in zebrafish (Yan et al., 2012), and endoge-
nous Zip7 was found to be expressed ubiquitously in early stages
of somitogenesis, but becomes concentrated around the retina
after 24 hpf. In adult fish, zip7 is also highly expressed in the
eyes and the brain. Zip7 zebrafish morphants have develop-
mental defects that include a curved notochord and small eyes.
Moreover, co-injecting zip7 mRNA or supplementing the sur-
rounding water with zinc significantly rescues the phenotypic
defects in zip7 morphants, suggesting that the developmental
defects are caused specifically by zip7 knockdown and are closely
related to zinc deficiency (Yan et al., 2012). The distribution pat-
tern of zinc was also compared between wild-type embryos and
zip7 morphants; the analysis revealed a significant loss of zinc
in the eyes of the zip7 morphants, and this was rescued by the
addition of exogenous zinc. These results suggest that Zip7 plays
a critical role in maintaining intracellular zinc levels in the eyes
and demonstrate that exogenous zinc supplementation can com-
pensate for Zip7 deletion, possibly through the activity of other
zinc-importing pathways. Indeed, in the zip7 morphants, the
expression levels of several zinc transporters are altered, includ-
ing zip3, zip6, znt2, znt5, and znt6 (Yan et al., 2012). This study
revealed the tissue-specific function of Zip7 and nicely illustrates
the dynamic interaction between environmental nutrient levels
and endogenous transcriptional regulation.
ZINC-REGULATED GENE EXPRESSION IN ZEBRAFISH
Zinc is required for the function of thousands of transcription
factors. Fluctuations in environmental zinc levels actively influ-
ence an organism’s various biological activities through transcrip-
tional regulation. Zebrafish is a convenient model for studying
the effect of fluctuating exogenous nutrients on endogenous gene
expression, as the nutrient concentration in the surrounding
water can be easily manipulated. In fish, the gill is a unique struc-
ture comprised of polarized epithelial cells; this configuration is
essential for the fish’s ability to extract zinc and other minerals
directly from the water. Importantly, the zinc transport system in
gills is highly conserved with the transport system in mammals.
Recently, two related studies examined the dynamic transcrip-
tome profiles of gills in zebrafish that were subjected to either
zinc depletion or zinc supplementation (Zheng et al., 2010a,b).
Juvenile zebrafish were exposed for 2 weeks to water that was
either zinc-enriched (4µM), zinc-normal (0.25µM), or zinc-
deficient (0.04µM). From 14 days of treatment, fish gill sam-
ples were collected from each group at multiple time points
and processed through microarray analysis in order to measure
changes in the transcriptome. In the group that received zinc
supplementation, most of the changes in the transcriptome were
associated with “transcription factors,” “steroid hormone recep-
tors,” and “development.” Additional data mining suggested that
these detected changes in the transcriptome were likely to be
induced by only a few key transcription factors, including Mtf1
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(the principal regulator of zinc-driven metallothionein expres-
sion), Jun, Stat1, Ppara and Gata3, reflecting a process similar
to hedgehog and bone morphogenic protein signaling. Moreover,
the transcriptional changes tended to slow after seven days of
treatment, suggesting that the fish gradually became acclimated
to the elevated zinc in the water (Zheng et al., 2010b). In the zinc-
deficient group, the most significant transcriptional changes were
found in genes associated with “developmental processes,” which
account for up to 26% of all regulated genes. The expression levels
of genes correlated with diabetes and bone/cartilage development
were also significant changed, which is consistent with previously
reported biological roles of zinc (Huang and Tepaamorndech,
2013). Several transcription factors were identified as key coor-
dinators of the homeostatic response to zinc depletion, including
Hnf4a, Foxl1, Wt1, Nr5a1, and Nr6a1 (Zheng et al., 2010a). Taken
together, these two complementary studies present a systemic,
longitudinal overview of the complicated changes that occur in
the transcriptome under abnormal environmental zinc levels.
The effect of changing environmental zinc levels on the regula-
tion of zinc transporter expression was also studied in zebrafish by
examining the expression patterns of zinc transporters in various
tissues under zinc-enriched and zinc-deficient conditions (Feeney
et al., 2005). The fish’s gills and intestine—two major sites of zinc
exchange in fish—had the largest differences in zinc transporter
expression. In contrast, the expression of zinc transporters in the
muscle and liver was affected the least (Feeney et al., 2005). Two
studies examined the transcriptional changes of zinc transporters
in fish gills in various zinc concentrations, and these studies
reported different sets of genes with altered expression. However,
both studies observed increased expression of znt5, zip3, and zip10
in the gills under zinc-deficient conditions and reduced expres-
sion of zip10 under zinc-enriched conditions (Feeney et al., 2005;
Zheng et al., 2008). Moreover, the inverse relationship between
zinc concentration and zip10 expression may be controlled by
metal-responsive clusters in two distinct promoters in the zip10
gene that have opposing regulatory roles in response to zinc avail-
ability; this process is potentially mediated by Mtf-1 (Zheng et al.,
2008). Interestingly, studies using mice have also suggested an
essential role for Mtf-1 in regulating Zip10 expression (Wimmer
et al., 2005; Lichten et al., 2011).
ZEBRAFISH AND COPPER METABOLISM
OVERVIEW OF COPPER METABOLISM
Copper is an essential nutrient that is present in nearly all living
organisms. Similar to iron, copper is a redox-active metal. Copper
functions as a key catalytic cofactor in a wide range of enzymes
and is therefore essential for many fundamental biological pro-
cesses, including cellular respiration, free radical detoxification,
connective tissue formation, and melanin production. Despite
its essential role in biology, excess copper is highly toxic due to
its high redox potential. Copper overload leads to the produc-
tion of ROS such as hydroxyl radicals, and the accumulation of
these radicals can cause devastating damage to cellular compo-
nents, ultimately causing cell death (Pena et al., 1999). In humans,
Menkes syndrome and Wilson’s disease are genetic diseases that
are caused by copper deficiency and copper overload, respectively
(Ala et al., 2007; Tumer and Moller, 2010).
The endogenous copper metabolism system can be divided
into three major steps (Figure 3): (i) copper uptake, (ii) intra-
cellular distribution of copper, and (iii) and copper export. The
high-affinity copper transporter 1 (CTR1) is the primary player
in the uptake of extracellular copper, whereas the low-affinity
copper transporter 2 (CTR2) is primarily intracellular and may
function to release copper from vesicles. Upon entry into the
cell, copper binds to a variety of cytosolic copper chaperones
and is then transported to specific subcellular destinations. The
three major copper chaperones are Copper chaperone for super-
oxide dismutase (CCS), Cytochrome c oxidase assembly protein
17 (COX17), and Antioxidant copper chaperone 1 (ATOX1). CCS
delivers copper to cytosolic superoxide dismutase 1 (SOD1) to
activate its function in mediating superoxide protection. COX17
transports copper to the mitochondria and facilitates its incor-
poration into Cytochrome c oxidase (CCO), the final enzyme in
the respiratory electron transport chain. ATOX1 carries copper
to copper-ATPases in the Golgi apparatus, from which copper is
then transferred to various cuproenzymes via secretory pathways.
The secretion of copper is also dependent on copper-ATPases.
ATP7A (the disease gene linked to Menkes syndrome) and ATP7B
(the gene that is defective in patients with Wilson’s disease)
encode two major types of copper exporters. When intracellular
copper levels are high, ATP7A and ATP7B are expressed in close
proximity to the basolateral and apical membranes, respectively,
where they export copper via vesicle-mediated fusion (Lutsenko,
2010). Approximately 95% of copper in the plasma is bound to
ceruloplasmin (CP), the principal circulating copper carrier. CP
is also a ferroxidase, serving as a molecular link between copper
and iron metabolism. The copper metabolism-related proteins
in fish and mammals are summarized in Table 5, and the cur-
rently available fish and mammalian models are summarized in
Table 6.
ZEBRAFISH MODELS OF COPPER METABOLISM
Identifying copper-deficient phenotypes in zebrafish
Unlike iron, which is directly related to anemia and hemochro-
matosis, many trace minerals do not cause specific phenotypes
when they are deficient or in excess. The identification of copper-
related phenotypes is essential for identifying animal models
to study mineral imbalance. A spectrum of distinct develop-
mental abnormalities was linked to copper deficiency through
a chemical genetic screen (Mendelsohn et al., 2006). Copper
has been proposed to play a role in melanin formation through
the activity of tyrosinase, a copper-containing oxidase (Rawls
et al., 2001). Using copper-induced reversible depigmentation
as a screening output, a library of small molecules was eval-
uated for their role in interfering with copper metabolism.
Notably, in addition to pigment loss, a specific combination of
other abnormalities was observed in all of the molecule-treated
embryos, including a wavy notochord, impaired cartilage and
vascular development, lack of hematopoiesis, and defective neu-
rogenesis. Adding copper—but not any other trace mineral—to
the water of molecule-treated embryos rescued the phenotypes
(Mendelsohn et al., 2006). Establishing these copper deficiency–
induced phenotypes in zebrafish greatly facilitated the discovery
of zebrafish with mutations linked to copper metabolism. The
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FIGURE 3 | Generalized overview of copper metabolism in vertebrate
cells. Extracellular copper enters the cell through the high-affinity CTR1
receptor. The CTR2 receptor primarily mediates the release of copper
from intracellular vesicles, but is also expressed in low levels in the
plasma membrane. Intracellular copper is bound by a variety of copper
chaperones and transported to various proteins in the following
intracellular sites: COX17 delivers copper to CCO in the mitochondria;
CCS delivers copper to cytosolic SOD1; and ATOX1 delivers copper to
copper-ATPases in the Golgi apparatus. Copper is secreted from the
basolateral and apical sides via ATP7A-mediatedand ATP7B-mediated
exocytosis, respectively. Proteins for which zebrafish knockout/knockdown
models are available are written in red.
role of copper in notochord development was suggested to be
related to lysyl oxidase, a cuproenzyme that may be impor-
tant for maintaining notochord sheath integrity (Csiszar, 2001).
Lysyl oxidase was further implicated in notochord develop-
ment through studies of zebrafish knockdown models, in which
lysyl oxidase morphants develop a notochord distortion that
is similar to copper-deficient fish (Gansner et al., 2007). It is
also notable that adding exogenous copper at an early stage
of development rescues all defects, suggesting that copper—and
likely other metals as well—can enter the embryo from the
surrounding water, presumably via transport through the cell
membrane.
Using the copper deficiency–linked zebrafish phenotypes as a
screening standard (Mendelsohn et al., 2006), a more recent study
examined nearly 3000 small molecules and identified a novel
panel of copper inhibitors (Ishizaki et al., 2010). Interestingly,
the authors combined the zebrafish phenotype screen with a
yeast chemical-genetics screen. The molecules that were identi-
fied from the zebrafish screen were used to treat a genome-wide
library of mutant yeast strains in order to identify novel genetic
pathways involved in copper metabolism. Select copper-related
genes identified from the yeast screen were then verified using
zebrafish knockdown models (Ishizaki et al., 2010). This flexi-
ble and powerful combination of zebrafish and yeast chemical-
genetics screening approaches will likely be useful in other studies
of diseases with identifiable phenotypes.
Atp7a
ATP7A plays important roles in exporting excess cytosolic cop-
per from the cell and in the delivery of copper to cuproen-
zymes via secretory pathways. In humans, mutations in ATP7A
cause Menkes syndrome, which has a broad spectrum of clin-
ical disorders that are related to copper deficiency, including
progressive neurodegeneration, connective tissue abnormalities,
and kinky, colorless hair (Tumer and Moller, 2010). After they
identified the copper-deficient phenotypes in zebrafish, the same
group performed an N-ethyl-N-nitrosourea (ENU) mutagen-
esis screen to search for mutants that mimic the chemically
induced copper-deficient phenotypes, particularly the pigment
loss and wavy notochord. This screen identified the calamity
mutant, which has the same set of developmental defects.
Positional cloning revealed that calamity mutants contain a
splice variant of the zebrafish homolog of atp7a; this alter-
natively spliced product causes a frame-shift and introduces
a premature stop codon (Mendelsohn et al., 2006). In fish,
the expression pattern of atp7a correlates with the phenotypic
defects, with strong expression in the developing notochord.
Moreover, the phenotype of the calamity mutants can be res-
cued by overexpressing human ATP7A, suggesting conserva-
tion of function (Mendelsohn et al., 2006). In addition, atp7a
zebrafish morphants have the same hypopigmentation and defec-
tive notochord phenotype as calamity mutants. Finally, a role for
Atp7a in modulating the expression of sp1 and sod1 has been
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Table 5 | Copper metabolism–related proteins in zebrafish, mice and humans.
Gene/Protein Function/Related diseases Tissue distribution Protein identity
(vs. H)
M% Z%
SLC31A1/CTR1 High-affinity Cu transporter/N.D. H Ubiquitous 92 72
M Ubiquitous
Z Entire embryo; larval brain liver gut; adult
gill, liver, gut, ovary
SLC31A2/CTR2 Low-affinity Cu transporter/N.D. H Salivary gland, placenta, spinal cord,
hypothalamus, blood
77 43
M Lacrimal gland, microglia, osteoclasts
Z N.D.
ATP6V0D1/ATP6V0D1 ATP catabolic process; ion transmembrane transport /
N.D.
H Ubiquitous 100 94
M Ubiquitous
Z CNS, epiphysis, integument,
mucus-secreting cells, neurons, pigment
cells, presumptive RPE, kidney, trigeminal
placode
ATP7A/ATP7A Cu-exporting ATPase/Menkes syndrome; occipital
horn syndrome; spinal muscular atrophy, distal,
X-linked 3
H Ubiquitous 90 65
M Ubiquitous
Z Neural tube, notochord, entire organism
ATP7B/ATP7B Cu-exporting ATPase/Wilson’s disease H Ubiquitous 82 62
M Ubiquitous
Z Liver
COX17 /COX17 Cu chaperone / N.D. H Ubiquitous 92 75
M Ubiquitous
Z Lens, myotome, pectoral fin musculature,
liver, gill
CCS/CCS Cu chaperone/N.D. H Liver, early erythroid cells 87 68
M Liver, kidney
Z Ubiquitous
ATOX1/ATOX1 Cu chaperone / N.D. H Ubiquitous 85 69
M Ubiquitous
Z N.D.
H, human; M, mouse; Z, zebrafish; N.D., not determined; CNS, central nervous system; RPE, retinal pigment epithelium.
suggested based on studies of atp7a morphants (Chen et al.,
2011).
Although the mottled mouse is a well-characterized animal
model of Menkes syndrome and has been studied for nearly 40
years (Hunt, 1974; Levinson et al., 1994), thanks to its unique
properties, the recently developed zebrafish Menkes model has
significantly increased our understanding of the underlying dis-
ease mechanism. The rapid and ex utero development of zebrafish
embryos has greatly facilitated the feasibility of performing exper-
iments during early embryogenesis. Embryonic transplantation
assays have revealed that transplanted wild-type cells can develop
melanin normally in calamity mutants, indicating that Atp7a
functions cell-autonomously. Furthermore, a combination of
copper-suppressing treatment and atp7a morpholino injections
revealed that the gene dosage of Atp7a determines the animal’s
sensitivity to copper deficiency (Mendelsohn et al., 2006). These
two novel findings obtained using the zebrafish atp7amodel sug-
gest new therapeutic strategies that focus on tissue-specific gene
replacement for treating patients with Menkes syndrome. The
zebrafish Menkes model is also a powerful tool for identifying
and screening potential compounds that can restore cuproen-
zyme function in the Atp7a mutant background using chemical
screens.
A rescue assay of two zebrafish atp7a mutants was conducted
via morpholino injection (Madsen et al., 2008). The same ENU
screen described above revealed a second allele of calamity, and
animals bearing this mutation have a phenotype that is similar
to animals with the first allele (Mendelsohn et al., 2006; Madsen
Frontiers in Pharmacology | Drug Metabolism and Transport March 2014 | Volume 5 | Article 33 | 16
Zhao et al. Zebrafish in mineral metabolism
Table 6 | Copper metabolism–related mouse and zebrafish knockout/knockdown models and their phenotypes.
Gene/Protein KO mouse models KO/KD zebrafish models References
SLC31A1/CTR1 Embryonic lethality; decreased copper
levels in the blood and several organsa,b
*Embryonic lethality; cell death in
the neural systemc
aLee et al., 2001; bNose et al., 2006;
cMackenzie et al., 2004
ATP6V0D1/ATP6V0D1 Mortality; premature agingd Embryonic lethality; pigment loss
with copper deprivatione
dMiura et al., 2003; eMadsen and Gitlin, 2008
ATP7A/ATP7A Perturbed copper metabolismf,g Pigment loss; abnormal skeletal
and notochord developmenth
fSchlief et al., 2006; gNiciu et al., 2007;
hMendelsohn et al., 2006
ATP7B/ATP7B Copper accumulation in various organs,
primarily the liver, kidney, and brain; a form
of liver cirrhosisi
N.D. iBuiakova et al., 1999
COX17 /COX17 Retarded growthj N.D. jTakahashi et al., 2002
CCS/CCS Increased sensitivity to paraquat and
reduced female fertilityk
N.D. kWong et al., 2000
ATOX1/ATOX1 Impaired intracellular copper trafficking
and postnatal mortality, retarded growth,
hypoactivity, loose skin,
hypopigmentation, seizuresl
N.D. lHamza et al., 2001
*Knockdown model.
et al., 2008). Noticing that both calamity mutants cause splic-
ing defects, the researchers attempted to rescue the mutants by
overexpressing antisense morpholino oligonucleotides designed
to specifically target the splice-site junctions in the two muta-
tions. Remarkably, the morpholino injections fully rescued the
copper-deficient defects in the calamity mutants and permitted
the production of wild-type Atp7a protein in all rescued embryos.
Nevertheless, although the rescued morphants had decreased
amounts of mutant mRNA, they did not have a significant
increase in wild-type mRNA, suggesting the presence of com-
petitive translational regulation (Madsen et al., 2008). This study
made available promising therapeutic options for using gene cor-
rection therapy to treat patients withMenkes syndrome, although
the feasibility of such an approach is currently limited by several
factors, including the nature of the mutations and the delivery of
morpholinos.
Small-molecule copper suppressors used in combination with
ENU mutagenesis screens identified zebrafish mutants that are
sensitive to limited copper availability (Madsen and Gitlin, 2008).
After treating with suboptimal doses of copper chelators (which
has no effect in wild-type embryos), developmental defects
(including pigment loss and an undulating notochord) were
detected in certain mutants that are phenotypically silent with
adequate copper supply (Madsen and Gitlin, 2008). Two sep-
arate copper-sensitive mutants were identified: a hypomorphic
allele of calamity and a novel mutant called catastrophe (cto).
Interestingly, in the hypomorphic calamitymutants, homozygous
embryos from homozygous mothers have reduced pigmentation;
this phenomenon does not occur in homozygous embryos from
heterozygous mothers, suggesting that the mutant’s copper sen-
sitivity is related to deficient loading of maternal copper into the
egg. The cto mutation is homozygous lethal, with homozygotes
developing small, punctate melanocytes; moreover, these animals
lose all pigments when treated with copper chelators. Cto mutant
have a mutation in Atp6, a vacuolar ATPase that is predicted to
play a role in proton translocation. Embryonic transplantation
of wild-type melanocytes restores normal melanin levels in cto
mutants, suggesting that the mutants have an intact copper
uptake system. However, a suboptimal dose of Atp7a morpholi-
nos completely blocks the production of melanin in the Atp6
mutants, suggesting a novel relationship between the proton
transport and copper secretory pathways (Madsen and Gitlin,
2008). This study revealed the mechanisms that underlie copper
metabolism by studying mutants that were identifiable only with
suboptimal copper supply, and it illustrates the value of using the
zebrafish model system to study gene-nutrient interactions.
Ctr1
CTR1 is a high-affinity copper importer that was originally iden-
tified in yeast (Dancis et al., 1994). Subsequent studies identified
human CTR1 as a potent copper transporter that is located pri-
marily in the plasma membrane (Lee et al., 2002). The role of
CTR1 in the absorption of dietary copper was further demon-
strated using a tissue-specific Ctr1-knockout mouse model (Nose
et al., 2006). The zebrafish Ctr1 protein shares approximately 70%
identity with the human homolog, particularly among the amino
acid residues that are essential for copper transport (Mackenzie
et al., 2004). Early in development, ctrl1 expression is generalized,
but then becomes concentrated in the intestine, which is consis-
tent with its role in the uptake of dietary copper. Ctr1-knockdown
fish are embryonic lethal, with massive cell death throughout the
neural system, including the brain and spinal cord (Mackenzie
et al., 2004). However, the mechanism by which Ctrl1 trans-
ports copper in zebrafish, and the protein’s role in embryogenesis,
requires further study.
ZEBRAFISH AND THE METABOLISM OF OTHER TRACE
ELEMENTS
SELENIUM
Selenium plays essential biological functions in the body, primar-
ily in the form of selenoproteins, which contain selenocysteine
amino acid residues. These functions include antioxidant defense,
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thyroid hormone production, and cancer prevention, The mech-
anisms by which selenium is absorbed and excreted vary based
on its chemical form in foods, and these mechanisms are poorly
understood (Mehdi et al., 2013).
Several zebrafish selenoproteins have been identified and
have a function that is conserved with human homologs, mak-
ing fish a powerful model for studying selenium metabolism.
The expression patterns of more than 20 selenoprotein genes
were analyzed in zebrafish embryos, and all of the examined
genes have tissue-specific expression patterns, many of which
reflect their known functions in mammals (Thisse et al., 2003).
Mutations in the human Selenoprotein N-encoding gene SEPN1
cause various forms of congenital muscular diseases called
SEPN1-related myopathies, which are characterized by early-
onset hypotonia and weakness (Lescure et al., 2009). During
somitogenesis, the zebrafish sepn1 gene is expressed specifi-
cally in the somites and notochord, which are the precursors
of skeletal muscle and vertebrae, respectively (Thisse et al.,
2003; Deniziak et al., 2007). Seph1-knockdown embryos have
reduced motility, poorly coordinated movement, and poorly
delimited myotome boundaries. At the ultrastructural level, mor-
phants exhibit pathological muscle changes, including defects
in sarcomere organization and myofiber attachment, as well
as altered myoseptum integrity (Deniziak et al., 2007). Thus,
the functions of zebrafish seph1 and mammalian SEPN1 are
strikingly similar, and studies of the zebrafish seph1 model
have yielded new insights into the pathological changes that
occur in human SEPN1-related myopathy and may serve as
an ideal model for future studies of disease mechanisms and
treatments.
On the other hand, the zebrafish selenium metabolism has
non-mammalian properties as well. Gene duplication is an inter-
esting genetic phenomenon in zebrafish selenium metabolism.
Two distinct genes that encode the selenocysteine tRNA[Ser]Sec
have been identified (Xu et al., 1999). Selenocysteine tRNA[Ser]Sec,
the principal component in selenoprotein biosynthesis, is
encoded by a single-copy gene in mammals and many other
classes. In zebrafish, the two tRNA[Ser]Sec genes have identical
coding sequences, and their flanking regions (several hundred
bases in length in both directions) are highly homologous, which
likely reflects evolutionary gene duplication in teleosts (Xu et al.,
1999). Similarly, multiple selenoprotein genes have been detected
in fish (Kryukov and Gladyshev, 2000). Two of the zebrafish
homologs of the human selenoproteins SEPT—glutathione per-
oxidase 1 and glutathione peroxidase 4—each have two genes in
the zebrafish genome. In addition, the zebrafish sepp gene con-
tains duplicated Sec insertion sequence elements and encodes a
protein containing 17 Sec residues, which is the largest number
of Sec residues in any known protein (Kryukov and Gladyshev,
2000; Tujebajeva et al., 2000). Finally, a novel family of seleno-
proteins called Sepu was identified in fish, chicken, and many
other non-mammalian species, suggesting the divergent evolu-
tionary distribution of selenoproteins in eukaryotes (Castellano
et al., 2004). Thus, although the zebrafish is a convenient and
powerful model for studying selenium metabolism, researchers
must be aware of key genetic differences between fish and
mammals.
MANGANESE
Manganese (Mn) is a key trace element associated with bone
development, superoxide elimination, and the metabolism of
amino acids, lipids and carbohydrates. Biologically, manganese
functions primarily as a cofactor of various enzymes, includ-
ing Mn superoxide dismutase (Mn-SOD), glutamine synthetase,
and arginase. Mn is transported through the body by transfer-
rin, macroglobulins, and albumin (Fraga, 2005). However, the
mechanism ofmanganesemetabolism in animals is poorly under-
stood. The zebrafish Mn-SOD has been cloned and shares 85%
sequence identity with the human homolog, including high con-
servation of the amino acids located in the Mn-binding sites. The
fish Mn-SOD gene is highly expressed during the early cleav-
age stage and has been suggested to be maternally distributed to
the eggs, indicating an essential role in embryonic development
(Lin et al., 2009). In addition, a Mn-dependent enzyme, ADP-
ribose/CDP-alcohol diphosphatase (ADPRibase-Mn), has been
functionally characterized in zebrafish (Rodrigues et al., 2012).
ADPRibase-Mn family members may play a role in the immune
system in vertebrates, as suggested by their expression patterns
in the rat (Canales et al., 2008). Similar to the rodent homolog,
the zebrafish ADPRibase-Mn is also Mn-dependent and catalyzes
the hydrolysis of ADP-ribose and CDP-alcohol. However, the
enzyme’s cyclic-ADP-ribose hydrolysis activity, which is robust in
rat ADPRibase-Mn, is negligible in the fish homolog, possibly due
to the lack of any known cyclic ADPR synthesis pathways in fish
(Rodrigues et al., 2012).
IODINE
Iodine is also a non-metal trace mineral. The primary biologi-
cal role of iodine is a constituent of thyroid hormones, which are
essential regulators of body growth, cell metabolism, and body
temperature maintenance. Zebrafish are an important model
system for studying thyroid development and function. Unlike
humans, zebrafish lack a compact thyroid gland. Nevertheless,
zebrafish thyroid tissue expresses genes that are critical for its
patterning and development, and these genes are conserved with
mammals (Porazzi et al., 2009). In zebrafish, thyroid hormones
play a role in regulating the differentiation of the pectoral fins
and determining the transition from the larval stage to the juve-
nile stage (Brown, 1997). Thyroid hormones are also essential
for the normal function of several physiological systems in fish,
including the cardiovascular system, the skeletomuscular system,
and the digestive system (Power et al., 2001). Therefore, zebrafish
can be an ideal model for studying thyroid diseases and iodine
metabolism.
CONCLUSIONS
Due to the availability of powerful genetic tools and its devel-
opmental advantages, the zebrafish has become an invaluable
model system for studying mineral metabolism. The gener-
ation of various zebrafish knockdown and knockout mod-
els has greatly facilitated the identification of novel genes
and mechanisms that underlie mineral metabolism, particularly
with respect to iron and copper, which produce characteris-
tic phenotypic changes when their concentrations are altered.
Moreover, the flexible combination of mutagenesis screening and
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metal chelation treatments, for example in studies of copper
metabolism (Mendelsohn et al., 2006; Madsen and Gitlin, 2008),
may be useful for identifying representative deficiencies that are
related to the metabolism of other metals. In addition, because
the zebrafish is an aquatic organism that develops ex utero, the
endogenous mineral levels in zebrafish can be readily altered by
changing the concentration of nutrients in the surrounding water,
even as early as embryonic day 0. Thus, the effect of dynami-
cally changing trace mineral levels on early development can be
studied quite conveniently in zebrafish (Ho et al., 2012). This
advantage also makes zebrafish an ideal tool for studying genetic-
nutrient interactions (Madsen and Gitlin, 2008). Furthermore,
the zebrafish is a vertebrate organism that is highly conserved
with humans, but is small in size and has rapid development,
making the zebrafish an ideal tool for studying the functional
consequences of gene mutations that have been identified in
mammals (De Domenico et al., 2007), for expanding cell-based
findings to the systemic/organism level (Devireddy et al., 2010),
and for confirming findings obtained from studying lower organ-
isms (Ishizaki et al., 2010). Finally, the results obtained using
zebrafish diseasemodels provide important directions for treating
human patients (Madsen et al., 2008).
The recent breakthroughs in reverse gene-editing
technologies—such as transcription activator-like effector
nucleases (TALENs) and the clustered regularly interspaced
short palindromic repeats (CRISPR)/Cas9 system—have greatly
facilitated the generation of loss-of-function fish mutants, which
in turn have enormously accelerated our ability to examine the
biological functions of many genes that had a previously elusive
relationship with trace mineral metabolism. Future studies such
as the construction of zebrafish mutant libraries of mineral
transporter proteins will allow researchers to gain important
insights into the field of mineral metabolism.
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